
ABSTRACT Aim To evaluate reproductive outcomes associated with discordance between Gardner morphology and KIDScore D5 in frozen–thawed single euploid embryo transfer cycles and explore developmental‐timing features associated with discordance. Methods This retrospective study included 217 frozen–thawed single euploid blastocyst transfer cycles from February 2020 to September 2024. Generalized estimating equations logistic regression models accounted for patient‐level clustering. Incremental value was assessed from model discrimination. Outcomes were compared among concordant and discordant Gardner morphology and KIDScore D5 classifications. Exploratory analyses examined developmental timing associated with classification patterns. Results Gestational sac formation, fetal heartbeat confirmation, and live birth occurred in 65.9% (143/217), 58.1% (126/217) and 53.9% (117/217) of cycles, respectively. Morphology was independently associated with all three outcomes; the adjusted odds ratio for live birth per one‐category increase was 1.95 (95% confidence interval, 1.35–2.84). KIDScore D5 was not independently associated with outcomes and did not significantly improve discrimination beyond morphology and clinical factors. Among 177 cycles with available KIDScore D5, live birth rates were 60.0% in the concordant group (105 cycles), 65.7% in the morphology‐higher‐than‐KIDScore group (35 cycles), and 29.7% in the KIDScore‐higher‐than‐morphology group (37 cycles). The latter had lower adjusted odds of live birth than the concordant group (adjusted odds ratio, 0.25; 95% confidence interval, 0.10–0.62). Exploratory analyses linked blastocyst formation timing with KIDScore D5 category and two‐cell and three‐cell timing with discordance contrasts. Conclusions In single euploid embryo transfers, morphology remained associated with outcomes, whereas KIDScore D5 provided limited incremental prognostic information. Discordance findings require independent validation.
ABSTRACT Aim Manual rotation is commonly used to correct fetal head malrotation during labor. This study assessed the effectiveness of manual rotation under neuraxial analgesia and evaluated whether transperineal ultrasound (TUS)‐derived parameters were associated with procedural success and could provide additional information when considering manual rotation. Methods We conducted a retrospective cohort study of 59 women with fetal rotational abnormalities during labor under neuraxial analgesia at a tertiary care center. Rotational abnormalities were defined as occiput posterior or occiput transverse positions with a midline angle (MLA) ≥ 45°, assessed 1 h after full cervical dilation. Manual rotation success was defined as correction to an MLA < 45°. Delivery, maternal, neonatal, and TUS‐derived parameters were compared between successful and unsuccessful cases. Results Manual rotation was successful in 44 of 59 cases (74.5%). The vaginal delivery rate was significantly higher in the successful group than in the unsuccessful group (90.9% vs. 46.7%, p < 0.001). No significant differences were noted in maternal or neonatal outcomes. Among TUS parameters, only the TUS‐station was significantly associated with procedural success. Receiver operating characteristic analysis identified a cutoff of 14.3 mm, above which the likelihood of successful rotation was 95.8%. In exploratory logistic regression models, TUS‐station remained associated with successful manual rotation after adjustment for clinically relevant covariates. Conclusions Manual rotation performed under neuraxial analgesia was associated with a high‐procedural success rate. A TUS‐station ≥ 14.3 mm was associated with a high likelihood of successful manual rotation and may provide complementary information when considering the procedure, although further validation is required.
ABSTRACT Aim To determine whether second‐trimester assessment of lower uterine segment microvascular blood flow using superb microvascular imaging complements residual myometrial thickness for predicting pregnancies at low risk of developing uterine scar dehiscence, a precursor lesion of uterine rupture after previous cesarean delivery. Methods This prospective study included 77 women with singleton pregnancies and at least one previous cesarean delivery. Transvaginal ultrasonography was performed at 19–21 and 25–27 weeks of gestation to measure residual myometrial thickness and assess lower uterine segment microvascular blood flow using superb microvascular imaging. Uterine scar dehiscence was diagnosed by macroscopic findings at cesarean delivery. Diagnostic performance was evaluated using receiver operating characteristic analysis, predictive values, likelihood ratios, and multivariable logistic regression. Results Seventeen women developed uterine scar dehiscence. Residual myometrial thickness was thinner and microvascular blood flow was detected less frequently in women with than without uterine scar dehiscence at both gestational periods. At 25–27 weeks of gestation, combining microvascular blood flow assessment with residual myometrial thickness improved discrimination over residual myometrial thickness alone (area under the receiver operating characteristic curve, 0.77 vs. 0.65; p = 0.02), improving exclusion of uterine scar dehiscence. After adjustment for residual myometrial thickness, microvascular blood flow remained independently associated with the absence of uterine scar dehiscence (odds ratio, 11.1; 95% confidence interval, 2.74–61.0; p = 0.0005). Conclusions Superb microvascular imaging provides information complementary to residual myometrial thickness. Combined second‐trimester assessment, particularly at 25–27 weeks of gestation, may improve prediction of pregnancies at low risk for developing uterine scar dehiscence.
ABSTRACT Aim Because completion of the guideline‐recommended postpartum oral glucose tolerance test (OGTT) remains low, we evaluated the feasibility of inpatient 75‐g OGTT among women with gestational diabetes mellitus (GDM) and described abnormal glucose tolerance and associated factors. Methods This retrospective single‐center study included 248 singleton pregnancies complicated by GDM delivered between January 2021 and December 2025. The primary outcome was inpatient OGTT completion. Abnormal glucose tolerance was defined by Japan Diabetes Society criteria as either borderline type or diabetic type. Secondary outcomes were the distribution of glucose tolerance categories and factors associated with an abnormal result. Results Inpatient postpartum OGTT was completed in 236/248 eligible pregnancies (95.2%). Of those, 171 (72.5%), 61 (25.8%), and 4 (1.7%) had normal‐type, borderline‐type, and diabetic‐type results, respectively; 65 (27.5%) were classified as abnormal. In the multivariable complete‐case model ( n = 223), maternal age (adjusted odds ratio [aOR] 1.11 per year, 95% confidence interval [CI] 1.03–1.20), number of positive antepartum OGTT points (aOR 1.75 per point, 95% CI 1.05–2.92), light‐for‐dates birth (aOR 3.89, 95% CI 1.11–13.62), and heavy‐for‐dates birth (aOR 3.28, 95% CI 1.43–7.55) were independently associated with an abnormal result. Conclusions Inpatient postpartum OGTT was feasible in this Japanese tertiary‐center setting and identified early dysglycemia. Inpatient testing may support counseling and follow‐up planning. However, this study did not evaluate whether it improved completion compared with conventional care or whether inpatient results predicted subsequent glucose tolerance. Timely postpartum reassessment remains necessary.
Aim To develop and internally validate a pretreatment quantitative magnetic resonance imaging-based predictive model for uterine fibroid volume reduction following gonadotropin-releasing hormone antagonist therapy.Methods In this single-center retrospective study, 106 women with uterine fibroids treated with relugolix underwent pre- and intratreatment magnetic resonance imaging. The dominant fibroid was assessed for T2-weighted imaging fibroid-to-iliopsoas signal intensity ratio, apparent diffusion coefficient, flow voids, and fibroid location. The primary outcome was a >= 30% reduction in dominant fibroid volume between pre and intratreatment magnetic resonance imaging. Eight baseline variables were entered into a Least Absolute Shrinkage and Selection Operator-penalized logistic regression model with bootstrap internal validation.Results Sixty patients (56.6%) achieved a >= 30% volume reduction. In the univariate analyses, a higher T2-weighted imaging signal intensity ratio and location were significantly associated with response. A purely data-driven Least Absolute Shrinkage and Selection Operator model retained two predictors: dichotomized T2-weighted imaging signal intensity ratio and location. A T2-weighted imaging ratio >= 2.0 was the strongest positive predictor, whereas subserosal and cervical locations showed negative associations and submucosal location showed a slight positive association relative to intramural fibroids. The model showed moderate discrimination (apparent area under the receiver operating characteristic curve, 0.746; optimism-corrected area, 0.671) with acceptable calibration.Conclusions Quantitative pretreatment T2-weighted imaging (ratio >= 2.0) is strongly associated with fibroid volume reduction under gonadotropin-releasing hormone antagonist therapy. An internally validated Least Absolute Shrinkage and Selection Operator-based model incorporating T2-weighted imaging signal intensity and location may aid individualized treatment selection and preoperative planning.